Serum monomeric α2-macroglobulin as a clinical biomarker in diabetes

Atherosclerosis

Volumn 228, Issue 1, 2013, Pages 270-276

  Takada, Tesshu ^a   Kodera, Yoshio ^b   Matsubara, Madoka ^a   Kawashima, Yusuke ^b   Maeda, Tadakazu ^b   Fujita, Yoshikuni ^a   Shichiri, Masayoshi ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

2 Macroglobulin; Cardiac isoform of 2 macroglobulin; Diabetes; Proteome

Indexed keywords

ALPHA 2 MACROGLOBULIN; BIOLOGICAL MARKER; TETRAMER;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; ION TRAP MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; ALPHA-MACROGLOBULINS; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; BLOOD PROTEINS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEINURIA; PROTEOMICS; YOUNG ADULT;

EID: 84876816338     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.02.035     Document Type: Article

References (30)

1. Harpel P.C. Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure. J Exp Med 1973, 138:508-521.
2. James K., Merriman J., Gray R.S., Duncan L.J., Herd R. Serum alpha 2-macroglobulin levels in diabetes. J Clin Pathol 1980, 33:163-166.
3. Lisowska-Myjak B., Pachecka J., Kaczynska B., Miszkurka G., Kadziela K. Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence. Acta Diabetol 2006, 43:88-92.
4. Ahmad J., Singh M., Saleemuddin M. A study of plasma alpha-2-macroglobulin levels in type 2 diabetic subjects with microalbuminuria. J Assoc Physicians India 2001, 49:1062-1065.
5. McMillan D.E. Alpha2-macroglobulin in diabetes. Lancet 1976, 2:1020-1021.
6. de Sain-van der Velden M.G., Rabelink T.J., Reijngoud D.J., et al. Plasma alpha 2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone. Kidney Int 1998, 54:530-535.
7. Ceriello A., Giugliano D., Quatraro A., Stante A., Dello Russo P., Torella R. Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. Acta Diabetol Lat 1989, 26:147-154.
8. Gray R.S., James K., Merriman J., et al. Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes. Horm Metab Res 1982, 14:389-392.
9. Watzke H., Schernthaner G., Schnack C., Schwarz H.P., Prskavec F., Freyler H. Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy. Diabetes Res 1988, 7:197-200.
10. Annapoorani P., Dhandapany P.S., Sadayappan S., Ramasamy S., Rathinavel A., Selvam G.S. Cardiac isoform of alpha-2 macroglobulin-a new biomarker for myocardial infarcted diabetic patients. Atherosclerosis 2006, 186:173-176.
11. Mariappan M., Selvamurugan N., Rajamanickam C. Purification and characterization of a high-molecular-weight protein induced in rat serum during the development of cardiac hypertrophy. Arch Biochem Biophys 1990, 281:287-297.
12. Prabhakar R., Rajamanickam C. Serum protein of 135-kDa molecular weight-a molecular signal for cardiac hypertrophy. Arch Biochem Biophys 1993, 302:425-430.
13. Rajamanickam C., Sakthivel S., Babu G.J., Lottspeich F., Kadenbach B. Cardiac isoform of alpha-2 macroglobin, a novel serum protein, may induce cardiac hypertrophy in rats. Basic Res Cardiol 2001, 96:23-33.
14. Rajamanickam C., Sakthivel S., Kurian Joseph P., Athimoolam Janarthanan R. A novel serum protein of molecular weight 182 kDa: a molecular marker for an early detection of increased left ventricular mass in patients with cardiac hypertrophy. J Cardiovasc Risk 1998, 5:335-338.
15. Rajan S., Radhakrishnan J., Rajamanickam C. Direct injection and expression in vivo of full-length cDNA of the cardiac isoform of alpha-2 macroglobulin induces cardiac hypertrophy in the rat heart. Basic Res Cardiol 2003, 98:39-49.
16. Moore R.E., Young M.K., Lee T.D. Qscore: an algorithm for evaluating SEQUEST database search results. J Am Soc Mass Spectrom 2002, 13:378-386.
17. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19:242-247.
18. Bjorhall K., Miliotis T., Davidsson P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005, 5:307-317.
19. Millioni R., Tolin S., Puricelli L., et al. High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity. PLoS One 2011, 6:e19603.
20. Kawashima Y., Fukutomi T., Tomonaga T., et al. High-yield peptide-extraction method for the discovery of subnanomolar biomarkers from small serum samples. J Proteome Res 2010, 9:1694-1705.
21. Eng J.K., Fischer B., Grossmann J., Maccoss M.J. A fast SEQUEST cross correlation algorithm. J Proteome Res 2008, 7:4598-4602.
22. White R., Janoff A., Godfrey H.P. Secretion of alpha-2-macroglobulin by human alveolar macrophages. Lung 1980, 158:9-14.
23. Milosavljevic T.S., Petrovic M.V., Cvetkovic I.D., Grigorov DNA binding activity of C/EBPbeta and C/EBPdelta for the rat alpha2-macroglobulin gene promoter is regulated in an acute-phase dependent manner. Biochemistry (Mosc) 2002, 67:918-926.
24. Armstrong P.B. Role of α2-macroglobulin in the immune responses of invertebrates. Invert Surviv J 2010, 7:165-180.
25. Rathinavel A., Dhandapany P.S., Annapoorani P., Ramasamy S., Selvam G.S. Cardiac isoform of alpha-2 macroglobulin as a novel diagnostic marker for cardiac diseases. Eur J Cardiovasc Prev Rehabil 2005, 12:601-603.
26. Subbiah R., Chengat V., Clifton J.D., et al. Cardiac isoform of alpha 2 macroglobulin and its reliability as a cardiac marker in HIV patients. Heart Lung Circ 2010, 19:93-95.
27. Padmasekar M., Nandigama R., Wartenberg M., Schluter K.D., Sauer H. The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways. Cardiovasc Res 2007, 75:118-128.
28. Watanabe T., Sato K., Itoh F., Wakabayashi K., Shichiri M., Hirano T. Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease. Sensors (Basel) 2012, 12:4974-4985.
29. Watanabe T., Nishio K., Kanome T., et al. Impact of salusin-α and -β on human macrophage foam cell formation and coronary atherosclerosis. Circulation 2008, 117:638-648.
30. Watanabe T., Suguro T., Sato K., et al. Serum salusin-α levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients. Hypertens Res 2008, 31:463-468.